Is the Thoughts and Health programme feasible in the context of Swedish schools? A quasi-experimental controlled trial study protocol. by Wikberg, Carl et al.
1Wikberg C, et al. BMJ Open 2021;11:e040374. doi:10.1136/bmjopen-2020-040374
Open access 
Is the Thoughts and Health programme 
feasible in the context of Swedish 
schools? A quasi- experimental 
controlled trial study protocol
Carl Wikberg   ,1,2 Pia Augustsson   ,1,2 Gudny Sveinsdottir,2 
W Edward Craighead   ,3 Erikur Örn Arnarson,4,5 Ina Marteinsdottir,6 
Josefine L Lilja   7
To cite: Wikberg C, 
Augustsson P, Sveinsdottir G, 
et al.  Is the Thoughts and 
Health programme feasible in 
the context of Swedish schools? 
A quasi- experimental controlled 
trial study protocol. BMJ Open 
2021;11:e040374. doi:10.1136/
bmjopen-2020-040374
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2020- 
040374).
Received 13 May 2020
Revised 07 December 2020
Accepted 17 December 2020
For numbered affiliations see 
end of article.
Correspondence to
Dr Carl Wikberg;  
 carl. wikberg@ allmed. gu. se
Protocol
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction Clinical depression is a substantial problem 
among adolescents, increasing significantly at about 
age 15 years. It causes impairment in social, academic 
and familial relationships, as well as ongoing cognitive 
and emotional difficulties for the individual. A study in 
Iceland demonstrated that a cognitive–behavioural, 
developmentally based intervention programme, ‘Thoughts 
and Health’, prevented initial episodes of depression and/
or dysthymia (DYS) (major depressive disorder/DYS) in 
adolescents for up to 12 months following completion 
of the programme. We would like to test the feasibility 
of implementing the Icelandic method in a Swedish 
context and to evaluate the long- term effects of such a 
programme.
Methods and analysis A quasi- experimental controlled 
design, combined with qualitative and quantitative 
methods, will be used to address the research questions.
In this study, 617 children aged ~14 years will be screened 
for depression, and those “at risk” for development of 
clinical depression will be offered a 12 week course, 
‘Thoughts and Health’. This course aims to prevent first 
depression in adolescents. A comparable group of children 
will function as controls.
Depending on the type of variable, baseline comparisons 
between the two groups of relevant initial measures will 
be evaluated with t- tests or χ2 analyses. The effects of 
the programme on the development of clinical levels of 
depression will be evaluated using the follow- up data of 6, 
12 and 18 months. Index parental depression at baseline 
will be tested as a moderator in the evaluation of the 
effects of the prevention programme.
Ethics and dissemination This study is approved by the 
Swedish Ethical Review Board (reference number 2019–
03347) in Gothenburg.
We plan to disseminate the knowledge gained from this 
study by publishing our results in peer- reviewed scientific 
journals and other scholarly outlets.
Trial registration number NCT04128644; Pre-results.
INTRODUCTION
Clinical depression is a substantial problem 
among adolescents, increasing significantly at 
about the age of 15 years. It causes impairment 
in social, academic and familial relationships, 
as well as ongoing cognitive and emotional 
difficulties for the individual.1 2
A study in Iceland demonstrated that 
a cognitive–behavioural, developmen-
tally based intervention programme called 
‘Thoughts and Health’ prevented initial 
episodes of depression and/or dysthymia 
(DYS) (major depressive disorder (MDD)/
DYS) among Icelandic adolescents for up 
to 12 months following completion of the 
programme.3 4 Other studies have demon-
strated that similar programmes can be 
employed to prevent depression among teen-
agers who have never been depressed and/
or who previously have been depressed.5–8 
The Thoughts and Health programme uses 
principles of both behavioural (eg, relax-
ation and behavioural activation (assertion 
and social approach)) and cognitive (eg, 
identification and modification of irrational 
thoughts, thinking errors and self- beliefs) 
interventions. The programme procedures 
were specifically adapted to the appropriate 
Strengths and limitations of this study
 ► Quasi- experimental controlled design will provide 
information about whether the intervention prevents 
depressive episodes in adolescence in a Swedish 
sample.
 ► Qualitative data will shed light on how the interven-
tion was perceived by the adolescents and how the 
personnel experienced the implementation process.
 ► Quantitative data will provide information regarding 
adolescents’ mental health and social functioning.
 ► Follow- up assessments will provide information 
regarding the intervention’s long- term effects on 
school performance and mental health.
 ► The study’s lack of a randomised controlled design 
and the few participants limit its generalisability.
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developmental level of the youth participants, with devel-
opmental level defined as stage 5 (identity vs confusion) 
of Erikson’s conceptual model of human psychosocial 
development.9 Specifically, stage 5 encompasses adoles-
cence, during which individuals develop a sense of self within 
the context of emerging independence from the family 
and expansion of interpersonal/social relationships.
However, despite the positive impact of such 
programmes, preventive effects have not been consis-
tently obtained.10–12 Reviews have concluded that 
universal prevention programmes (programmes applied 
to the general population) have not been effective in 
preventing depression13 14, and excellently conducted 
studies in Australia have provided data consistent with 
that conclusion.15 16 In general, only targeted programmes 
(selective programmes—for populations exposed to risk 
factors, or indicated programmes—for populations who 
are experiencing some symptoms) have shown significant 
short- term effects in preventing depression.1 5–7
Most programmes aimed at preventing depression have 
included both youth who have suffered a prior depres-
sion and those who have never been depressed. The study 
of prevention of relapse or recurrence in prevention 
programmes for those who have already suffered an MDD 
is clearly useful, but earlier studies have not distinguished 
between prevention of the first episode of MDD and the 
prevention of relapse/recurrence of MDD. However, 
because of the recurrent nature of the disorder and the 
differing causal factors and probability patterns of first 
versus subsequent episodes17 and in order to prevent 
the deleterious effects of an episode of MDD on youth, 
it is especially important to study the prevention of the 
first or initial episode among never previously depressed 
subjects.
Since clinical depression among adolescents increases 
significantly at about the age of 15 years, and Swedish chil-
dren finish their compulsory school (junior high school) 
at that age, being at risk of depression can be a reason 
for failing their final examinations, thereby limiting their 
chances for further academic studies.
We would like to test the feasibility of implementing the 
Icelandic method in a Swedish context and to evaluate the 
long- term effects of such a programme. We would like to 
test the method with a quasi- experimental controlled trial 
and to evaluate the outcomes after 6, 12 and 18 months. 
The control group will be assessment- only adolescents; 
they receive ordinary ‘Student Health’; they participate 
in all study assessments, but they are not offered the inter-
vention Thoughts and Health.
This is, to our knowledge, the first study in Sweden that 
employs a longitudinal design to evaluate the effects of a 
school- based programme aimed at preventing depression 
in adolescents.
This study will be implemented together and within the 
municipalities of Tjörn and Orust, two islands off the west 
coast of Sweden, with each island having only two middle 
schools. Thus, this study is built on a close collaboration 
between academia, primary care and the community.
We are hopeful that this programme will be transfer-
rable to a Swedish context and that it will be possible 
to further develop and enhance the method. Although 
Iceland and Sweden are similar in many ways, the school 
system and cultural context differ to some extent.
We hypothesise that programme implementation will 
reduce the risk of developing depressive symptoms among 
participating students compared with their control coun-
terparts, and we will examine this in participating adoles-
cents up to 18 months after programme completion. 
We also hypothesise that adolescents in the intervention 
group who participate in the programme will finish school 
with complete grades to a greater extent (more students 
complete their schooling) than the control group.
AIM
This study aimed to test the feasibility of implementing an 
Icelandic cognitive–behavioural programme designed to 
prevent depression, Thoughts and Health,3 4 in a Swedish 
school setting.
The perspectives of both the participating adolescents 
and the primary care professionals who lead and support 
the programme in the schools will be taken into account 
when evaluating the programme’s feasibility.
The study also aimed to evaluate the number of students 
who finish junior high school (ninth grade, ~15 years 
old) with complete grades. In this study, the outcomes 
concerning complete grades of the students participating 
in the intervention programme will be compared with the 
complete grades of those in the control group.
Our primary research questions are
Is the Thoughts and Health programme feasible in the 
context of Swedish schools, from the perspective of the 
students participating in the programme?
Is the Thoughts and Health programme feasible in the 
context of Swedish schools, from the perspective of the 
primary care professionals leading and supporting the 
programme implementation?
Our secondary research questions are
Does participation in the Thoughts and Health pro-
gramme affect the number of students developing de-
pressive symptoms?
Will participation in the course Thoughts and Health 
increase the participants' chances of completing com-
pulsory school with high school eligibility?
METHOD
Study design
A quasi- experimental controlled design combined with 
qualitative and quantitative methods will be used to 
address the research questions ( Clinicaltrials. com).
We have used the SPIRIT reporting guidelines.18
Participants
An invitation regarding participation in the study to high 
schools in the area resulted in four junior high schools 
from the municipalities of Tjörn (Häggvall and Bleket, 
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intervention arm) and Orust (Henån och Ängås, control 
arm) that will participate in the study. The allocation of 
the schools was chosen on the basis of their rural location 
and socioeconomic similarity, willingness to participate 
and available staff. Since all schools had shown interest 
in participating in this study, the assignment of interven-
tion and control arms was determined on the basis of 
available resources; therefore, Tjörn was chosen for the 
intervention programme at this stage. Two intervention 
courses were planned (I and II), with course I beginning 
at the start of the fall semester (~1 September) 2019 and 
course II beginning at the start of the fall semester (~1 
September) 2020.
In total, approximately 320 eighth grade Swedish 
adolescents aged 14 years will participate in a preinterven-
tion screening process per course. In the preintervention 
screening process, all students will complete the Chil-
dren’s Depression Inventory (CDI, described further)19 
assessment instrument via an online questionnaire tool. 
This will be part of the existing “Student Health” ordinary 
assignments that include health and mental health status 
checkups as per the Swedish School Law.
We are aware of the small number of students that will 
be part of the collected data at this early stage, and we 
are planning a full- scale randomised trial once we have 
completed this first study; hence, there were no power 
calculations of sample size at this stage.
All students who score at or above the 75th percentile 
on the CDI screening will be qualified initially for possible 
inclusion in the study (expected n=80 total per course). 
They will receive an invitation together with their parents 
to attend a psychological assessment interview (the Mini 
International Neuropsychiatric Interview for Children 
and Adolescents (MINI- KID), described further).20 At 
the interview, they will be given the opportunity to discuss 
their CDI result and if needed, to be channelled to the 
right level of care (eg, if a student scored very high on 
CDI, the psychologist will need to decide whether there 
is any underlying diagnosis that requires treatment or if 
the student has any other condition that also requires 
immediate attention and treatment). If a student is 
diagnosed with depression at this phase, he or she will 
no longer be eligible to participate in the study and will 
be directed to appropriate mental healthcare resources 
in the community. Prior to attending this psychological 
assessment, students and their parents will separately fill 
out the Revised Children’s Anxiety and Depression Scale 
(RCADS)21 assessment instrument.
Based on the MINI- KID results, students who meet 
criteria for having any current or past major depression, 
DYS, bipolar disorder I or II, cyclothymia, anorexia, 
bulimia, psychotic disorder, alcohol or substance 
dependence, attention deficit hyperactivity disorder, 
oppositional defiant disorder or conduct disorder will 
be excluded. All other students thus fulfil the inclu-
sion criteria. All students, both in the intervention and 
control arms, will be invited to participate in the study 
via an appropriately worded letter (expected n=40 total 
per study arm). See table 1 for inclusion and exclusion 
criteria.
Thus, about 20 students per course will be offered 
to participate in the intervention programme. These 
students will be approached by the programme staff 
and offered the opportunity to participate in the base-
line clinical interview and assessment, the intervention 
programme, and postintervention follow- up assessments 
at 6, 12 and 18 months after programme completion 
(figure 1).
Participants in the intervention and control arm will be 
offered tickets to the cinema as a gesture of gratitude for 
their participation in each of the follow- up assessments.
Measures and assessments
Measures and assessments are described as follows. The 
instruments, persons involved and the time point for each 
measure or assessment are shown in table 2. All psycho-
metric measures are administered by esMaker (htpps://
entergate.SE/products/esmaker/). Course surveys 
are distributed in the form of hard copies. If partici-
pant frequency is shown to be low, those who have not 
completed the measures will receive a reminder by email.
Outcomes
CDI, ordinal variables (collected during preintervention phase, at 
course start, and at 6, 12 and 18 months of follow-up)
The CDI is a 27- item self- reported, symptom- oriented 
scale that rates the severity of depression during the past 
month. It is designed for children/adolescents, ages 7–17 
years. Each of the 27 items comprises three sentences 
used by the student to rate the severity of the symptoms. 
This inventory has previously shown excellent internal 
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Eighth grader Ongoing or past depression
Guardian of eighth grader Addiction
Understand Swedish 
language skills, written and 
oral
Past or current suicidal attempt or 
ideation
Be able to fill out 
questionnaires 
independently
Neuropsychiatric diagnosis that 
precludes group activities
Completed CDI and be 
above 75th percentile
Not high enough level of function 
on the CGAS (cut- off≥61)
Completed psychological 
assessment
Lacking sufficient Swedish 
language skills, written and oral
Written and oral consent Serious mental illness
  Ongoing other psychotherapeutic 
treatment
*Assessed and determined by a psychological assessment, 
based on the clinical rating instruments CDI, MINI- KID, RCADS 
and the children’s current status.
CDI, Children’s Depression Inventory; CGAS, Children’s 
Global Assessment Scale; MINI- KID, Mini International 
Neuropsychiatric Interview for Children and Adolescents.
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consistency (Cronbach alpha coefficients of 0.83–0.94). 
The present study uses the total score of the Swedish 
version of the CDI.19 The CDI will be used both in 
screening and in follow- ups with participating children.
RCADS, ordinal variables (collected during preintervention phase 
and at 6, 12 and 18 months of follow-up)
RCADS is a widely used questionnaire designed to assess 
clinical syndromes of anxiety as well as depression, based 
on the Diagnostic and Statistical Manual of Mental Disorders 
(DSM), Fourth Edition, criteria. The RCADS provides 
two total scores and has six subscales: separation anxiety 
disorder, social phobia, obsessive–compulsive disorder, 
panic disorder, generalised anxiety disorder (GAD) and 
MDD. The internal consistency of the RCADS subscales 
is high, with Cronbach alphas ranging from 0.78 to 0.88. 
There are two versions of RCADS: one for adolescents 
(RCADS) and one for parents (RCADS- P).
MINI-KID, categorical variables (collected during preintervention 
phase and at 6, 12 and 18 months of follow-up)
The MINI- KID is a structured interview for children 
and young people aged 4–17 years old.20 It is based on 
diagnoses using the DSM, Fifth Edition,22 and the 10th 
edition of International Statistical Classification of 
Diseases and Related Health Problems. Both parents and 
youths will participate in the interview, but the interview 
can also be conducted with only young people. The inter-
view aims to ensure diagnosis and inclusion/exclusion 
criteria.
Demographic information and somatic health, categorical variables 
(collected at course start and at 6, 12 and 18 months of follow-up)
The baseline questionnaire will include items regarding 
sociodemographics, physical activity, drug use, and some 
questions about mobile and internet usage.
Children’s Global Assessment Scale (CGAS) ordinal variables 
(collected during preintervention phase)
The CGAS will be used to measure global functioning.23 
The assessment will be made by the person who conducts 
the MINI- KID interview. The CGAS estimate is made on 
a scale of 1–100, where a higher score indicates a higher 




Anticipated analysed (n= 15)
Excluded from analysis (give reasons) (n=?) 
Post intervention
6, 12 and 18 months.
Assessed (n= 40)
Met inclusion criteria (n= 30)
Included after consent (n= 15)
Post intervention
6, 12 and 18 months.
Assessed (n= 40)
Met inclusion criteria (n= 30)
Included after consent (n= 15)
Anticipated analysed (n= 15)









over 75e percentile 
Control 
2 Schools (n=40),
over 75e percentile 
CDI at school
All children who score above the 
75e percentile will be invited to a 
Psychological assessment. 
Figure 1 Flowchart over the Thoughts and Health study.
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Education Work and Social Adjustment Scale (EWSAS) ordinal 
variables (collected at course start, course middle (6 weeks after 
course start), and at 6, 12 and 18 months of follow-up)
The EWSAS measures general level of function.24 It is 
an adaptation of the Work and Social Adjustment Scale 
and measures the level of function in five areas: relation-
ships, family, leisure time, social activities, and school and 
everyday activities. This will be completed by participating 
children.
Mental Health Continuum–Short Form (MHC-SF), ordinal variables 
(collected at course start, course middle (6 weeks after course 
start), and at 6, 12 and 18 months of follow-up)
The MHC- SF is an increasingly used questionnaire that 
measures three components of well- being: emotional, 
social and psychological. It has shown excellent internal 
consistency (>0.80) and discriminant validity in adoles-
cents (ages 12–18 years) and adults in the USA, in the 
Netherlands and in South Africa.25–28 MHC- SF consists of 
14 items asking about the frequency of well- being expe-
riences during the last month. There are three items 
concerning emotional well- being, such as feelings of 
being happy, interested in life and satisfied, five items 
concerning social well- being, reference, actualisation, 
contribution, coherence and integration, and six items 
concerning psychological well- being capturing purpose in 
life, environmental mastery, autonomy, personal growth, 
positive relations and self- acceptance. Answers are given 
on a 6- point Likert scale from 0=never, 1=once or twice, 
2=about once a week, 3=about two or three times a week, 
4=almost every day and 5=every hour. Cronbach’s alpha 
was 0.92 for emotional well- being, 0.88 for social well- 
being and 0.92 for psychological well- being. Scores on 
each well- being component are summed and categorised 
as ‘flourishing’, ‘moderately healthy’ or ‘languishing’ 
according to official MHC- SF guidelines. The MHC- SF 
has been useful in improving the scientific understanding 
of the risk of future mental illness (major depressive 
episode, GAD, panic attacks, risk of premature mortality, 
healthcare use, missed days of work, suicidality and self- 
reported academic impairment among college students). 
The MHC- SF will be completed by participating children.
Parental depression, binary variable (collected during 
preintervention phase)
At the time of the baseline interview, adolescents will be 
asked if their parents have previously suffered from or 
currently suffer from depression. Similarly, parents will be 
asked if they have previously suffered from or currently 
suffer from depression. These data are collected because 
there are known associations between depression in 
parents and the health of their children.6 We would like 
to know if any of the parents have had or currently have 
a depressive episode as that may be related to the depres-
sive outcomes in their children. Both adolescent and 
parent data will be analysed separately. This will be useful 
for further analysis regarding long- term follow ups. As 
an example, we will be able to see whether intervention 
group and control group parents are similar regarding 
possible previous or current state of depression.















MINI- KID x x x x x
CGAS x x x x x
Clinical Global 
Impressions (CGI) x x x x
Self- rated instruments
CDI x x x x x x x
RCADS x, o x x x x x
EWSAS x x x x x x
MHC- SF x x x x x x
Baseline Questionnaire x, o x, o x, o x, o x, o
Course surveys x x x x x




Parents: o, adolescents: x.
CDI, Children’s Depression Inventory; EWSAS, Education Work and Social Adjustment Scale; MHC- SF, Mental Health Continuum–Short 
Form; RCADS, Revised Children’s Anxiety and Depression Scale.
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Course surveys, ordinal variables (collected after each course 
session)
After each course session (total of 12 sessions per course), 
the students and the primary care professionals leading 
and supporting the course will directly provide their feed-
back about the course session by answering a short survey. 
Different surveys will be provided to students and the 
professionals, respectively. These surveys will assess feasi-
bility, satisfaction and overall impression of the session.
Course attendance and dropouts, binary variables (collected during 
each course session)
Attendance and dropouts will be recorded at each course 
meeting, as a measure of the feasibility and acceptance of 
the programme.
Focus groups and interviews, qualitative analysis (collected within 
1 month after course end and at 18 months follow-up)
All participants (students and professionals) will be 
invited to take part in focus group discussions or indi-
vidual interviews after the completion of the full course. 
These discussions will be held separately, with students in 
one or two groups and the professionals in another, or as 
individual interviews. Focus groups will be held with the 
students and individual interviews with professionals.
Final junior high school grades, categorical variables (collected at 
approximately 18 months after course end)
Students’ final grades in junior high school (ie, in 
ninth grade, or 18 months after their inclusion in the 
programmes) will be collected to be able to evaluate 
the number of students who finish school with complete 
grades. The information will be provided by the school 
administration on consent (online supplemental file) 
from the students.
All psychological assessments will be conducted by a 
trained psychologist from the primary care centre, and 
the focus groups and interviews will be conducted by the 
authors CW (PhD and specialist nurse) and PA (PhD 
student).
Data management
A research journal will be used to follow up the person 
during the programme and follow- up period. The 
research journal will be kept at the primary care research 
and development unit, Kungsgatan, in Gothenburg, 
where data from the research journal are entered. Data 
in the database at the research unit will only be entered 
with code numbers. Only the research leaders will then 
have access to the code key, which is stored in in a locked 
safe at the research unit. The research journals will be 
kept at the research unit and will be anonymised during 
the evaluation phase. The composition of the research 
group may change during the course of the project, but 
only authorised persons who are part of the research 
group will have access to data. The usual privacy is 
maintained.
Intervention: prevention programme
The prevention programme will be based on the Icelandic 
Thoughts and Feelings programme1 and will include 12 
group sessions of 90 min duration, delivered two times 
per week for 2 weeks and then once a week for 8 weeks in 
the school setting by Student Health school psychologists. 
School nurses will also attend each session as support 
for the students. The programme uses two intervention 
manuals: a group leader manual and a student manual. 
Both of these manuals have been translated first from 
Icelandic to English, and then from the English version 
into Swedish, and finally corrected for language in the 
Swedish version. After translation, the manuals were 
additionally reviewed by several eighth- grade students 
for cultural acceptability (eg, word choice) and adapted 
as per their feedback. The course material is based on 
cognitive behaviour theory, and the course will be held as 
a group activity. The course was originally developed as a 
group activity, and we will test this method in our study, as 
part of the evaluation of whether the method is suitable 
for Swedish adolescents of today. The course contains 
group sessions focusing on a specific topic, after which 
they will describe their state of health and feelings in a 
diary and receive some home assignments to be completed 
between sessions. All sessions start with a light refresh-
ment and a summary of the previous session. Session #1 
is an introduction. Session #2 is about ‘the spiral’, that 
is, how negative or positive thoughts and actions affect 
subsequent actions and feelings. Session #3 is about relax-
ation. Session #4 will discuss the concept of a ‘baseline’. 
The remaining sessions deal with the following topics: 
setting targets (session #5), feelings (session #6), negative 
thoughts (session #7), irrational thoughts (session #8), 
self- perception (session #9), communication (session 
#10), stop and reconsideration (session #11) and course 
consummation (session #12, final session).
Statistical analysis
Depending on type of variable, baseline comparisons 
of the two groups of relevant initial measures will be 
evaluated with t- tests or χ2 analyses. The effects of the 
programme on the development of depressive symptoms 
will be evaluated for the data of 6, 12 and 18 months using 
the Cox proportional hazards model to estimate survival 
curves and rates for different thresholds of combined 
scores of depressive symptoms. Index parental depression 
at baseline will be tested as a moderator in the evaluation 
of the prevention programme effects. Even though the 
sample in this part of the project is rather small, we will 
stratify all results by selected measures collected in the 
baseline questionnaire including gender, socioeconomic 
status and mobile/internet use, among others. With 
regard to the small sample size in this early stage of the 
study, dropouts or non- completion of outcome measures 
will be analysed with intent- to- treat.
The qualitative data collected through interviews and 
focus group discussions will not require any statistical 
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analysis, but they will be analysed using thematic qualita-
tive analytical methods.
Ethics and dissemination
This study is approved by the Swedish Ethical Review 
Board (reference number 2019–03347) in Gothenburg. 
Since participants are adolescents aged <15 years, consent 
from both parents (all parents if eligible) and the adoles-
cents themselves will be obtained, as required by appli-
cable laws and regulations.
This study is based on a validated programme that has 
been conducted in other countries showing good preven-
tive effect. Based on previous studies, we expect preventive 
effects of the intervention in the participating adoles-
cents. To ensure that the risks are minimal throughout 
the programme implementation and follow- up, we will 
provide all participants from the preintervention phase 
through postintervention follow- up, in both control and 
intervention arms, with access to professional help in 
the form of psychologists, doctors and nurses if needed. 
The research group has solid experience implementing 
the treatment programme in other settings; their experi-
ence indicates that the intervention is perceived as posi-
tive by students and that participation in the group work 
has not been stigmatising. All measures and assessments 
used in the study are validated and tested in many other 
studies. All researchers and professionals in this study 
have good paediatric psychiatric competence. They are 
accustomed to talking with adolescents and will be able to 
carefully and sensitively handle unpredictable situations. 
All personnel involved in the study undergo training in 
the intervention. The research team is trained in good 
clinical practice (GCP) (scientific quality and ethical stan-
dards for planning, conducting, recording and reporting 
trials involving human participation). The study subjects 
will never be alone during the intervention because the 
intervention is carried out in groups and by trained staff. 
We will ensure the privacy of study participants, and all 
relevant legislation will be followed regarding use of 
research data. All members of the research group have 
undergone training in the intervention by the founders of 
the programme. The research group consists of general 
practitioners, psychologists, specialist nurses and social 
workers. The trial manager is a specialist psychologist 
and a PhD, and the implementation leader is a specialist 
nurse and PhD. The founders of the programme are both 
professors of psychology, one in the USA and the other 
one in Iceland.
Results from the study will be presented so that no indi-
viduals, including students, parents and the employer 
representatives, will be identifiable. All results will be 
presented on a group level. All participation is voluntary, 
and the student can withdraw from the study at any time.
The trial will be conducted in compliance with this 
study protocol, the Declaration of Helsinki and its modi-
fications, and GCP.
We plan to disseminate the knowledge gained from this 
study by publishing our results in peer- reviewed scientific 
journals, giving presentations at national and interna-
tional conferences, and spreading information through 
local and national media channels. We will approach 
local and national politicians to ensure prolongment of 
the project.
DISCUSSION
The study protocol of this research project shows that 
the planning and organisation of the research make it 
feasible to answer the four research questions.
Question (1). Is the Thoughts and Health programme 
feasible in the context of Swedish schools, from 
the perspective of the students participating in the 
programme? The answer will be based on the qualitative 
interviews and focus group discussions conducted with 
adolescents participating in the intervention group, as 
well as analysis of the course surveys gathered after each 
session and analysis of possible dropouts.
Question (2). Is the Thoughts and Health programme 
feasible in the context of Swedish schools, from the 
perspective of the primary care professionals leading and 
supporting the programme implementation? The answer 
will be based on the analysis of interviews with the profes-
sionals who have taken part in individual interviews after 
the completion of the intervention course, as well as anal-
ysis of the course surveys gathered after each session.
Question (3). Does participation in the Thoughts and 
Health programme have an effect on the development 
of depressive symptoms? The answer will be based on 
collected data and statistical analyses. Outcomes will be 
collected before, at and after baseline, based on adoles-
cents’ and adults’ reports. Comparisons of effect sizes will 
be made between the arms of the study (control schools 
and intervention schools). Measures are described in the 
protocol and in table 2.
Question (4). Will participation in the course 
Thoughts and Health increase the participants' chances 
of completing middle school with high school eligibility? 
The answer will be based on follow- up measurements of 
completion and final grades at graduation from middle 
school. Comparisons of effect sizes will be made between 
the arms of the study (control schools and intervention 
schools).
Current trial status
Recruitment of participants started in September 2019, and 
the last participant is expected to reach the primary endpoint 
(18- month follow- up) in April 2021. Primary data analysis will 
begin in May 2021. The naturalistic follow- up phase of the 
trial will continue until October 2022.
Patient and public involvement
We will receive input from participants and professionals 
from focus group discussions and interviews, which will guide 
the continuation of the intervention study. In the current 
trial, no participants were involved in the design of the study 
or in the decision of outcome measures.
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Open access 
Members from the public or students were not involved 
in designing this study.
We will assess the effect of the trial interventions on the 
participants by collecting information through e- mailed self- 
rating questionnaires at the end of programme.
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Mental illness in young people is a growing problem in Sweden and a large part of the world. 
Depression is one of the diseases that has the greatest social and economic consequences globally and leads to 
great human suffering. A first illness often occurs in late adolescence. A first depression increases the risk of 
relapse. 
 
Preventive efforts to reduce the risk of a first illness should be regarded as an important measure to improve 
young people's mental health and opportunities for a positive entry into adulthood. 
 
Children with depression at the end of junior high school may risk not being able to finish their compulsory 
schooling with complete grades, which in turn may affect their future opportunities. 
 
We have now translated and adapted a prevention programme from Icelandic to Swedish. We would like to 
test whether this programme works in Swedish schools. 
 
In collaboration with Elevhälsan Tjörn Municipality and Orust Municipality and Närhälsan's health centres in 
the local area and Närhälsan's Research and Development Department, we now want to offer students in 
these municipalities the opportunity to help us  implement the programme and at the same time fill important 
knowledge gaps in research. 
 
Purpose 
To study the effects of an Icelandic prevention programme "Thoughts and health" in Swedish schools. 
 
Request for participation 
You are now asked as a student in year 8 on Tjörn for consent to participate in the study and the Thoughts and 
Health programme. 
 
How is the study done? 
 
All children at the school have been asked to fill out a form with questions about their mental health. All 
children will receive feedback about the results.  Some will receive feedback during their health talk with 
 
the school nurse while others will be offered feedback and assessment by psychologists associated with the 
project for possible inclusion in the prevention programme. The programme consists of a course involving 12 
sessions at the school that are led by a psychologist and the school nurse. The group(s) is put together based 
on the number of possible participants per school, which means that the composition does not depend upon 
which class you are in. For you, this means that you will be asked to fill out forms at the start, when half the 
programme is completed and again at follow-ups. As a participant in the programme, you can of course talk to 
your parents or guardians about the content of the course, but you should not tell about other participants' 
experiences. Everyone who is part of the programme or the reference group that is included will be followed 
up after the end of the programme, at 6, 12 and 18 months. The results from the first questionnaire and the 
psychologist's assessment are included in the data collected. 
 
Data management and confidentiality 
 
All answers and results will be treated with confidentiality so that unauthorized persons cannot take part in 
them. 
Personal data is registered in accordance with GDPR (The General Data Protection Regulation). The 
investigator responsible for the study is entrusted with the processing of personal data. According to the 
GDPR, you have the right to apply for information about which personal data is processed and to demand 
destruction of the personal data. You and your parents can send your application to the contact person below. 
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If you want to submit a complaint regarding the processing of personal data, you can contact the Data 
Inspectorate, which is the supervisory authority for the Data Protection Ordinance. Please note that the Data 
Protection Officer cannot answer questions concerning specific information about the study but only regarding 
the application of the Data Protection Regulation. 
Contact details of the Data Protection Officer: Anders Larsson, Information Security Coordinator Phone: 070-
6552809 anders.h.larsson@vgregion.se 
In data processing, your name and personal identity number will be replaced with a code to ensure anonymity. 
Only those responsible for the study have access to the "code key". Your information will not be passed on. 
The data will be saved for ten years. The authority responsible for your personal data is primary care Västra 
Götaland. Lina Kolsmyr tel. 
010-441 05 30, narhalsan.dataskyddsombud@vgregion.se Personal data representative Närhälsan, 
Lillhagsparken 6, 422 50 Hisingsbacka. When the data from the study is compiled, individual individuals will not 
be able to be identified. 
 
Remuneration 
No remuneration will be given for participation. 
 
Volunteering 
Your participation is voluntary and you can cancel your participation at any time without giving any reason. 
 
What does the study mean for you and other children in the future? 
That you may contribute to the development of student health and that by participating in the research 
project, you may provide answers to important questions regarding mental health. Your participation will help 
us to study this prevention programme against depression, the aim of which is to create good routines that in 
the long run may lead to improved mental health for children and young people. 
 
Persons responsible for the study 


















FoU Primärvård, Göteborg- och Södra Bohuslän 
PhD, Spec. klinisk psykolog, leg. psykoterapeut-KBT, Handledare-KBT 
josefine.lilja@vgregion.se 
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I have been informed, given the opportunity to ask questions, have them answered and agreed to 
participate in the study and been informed about the right to integrity when the material is published. I 
have also been informed that my participation in the study is voluntary and that I am right at any time 
to interrupt my participation in the study without giving a reason and without it affecting my 
contact with primary care or school. 
 
 
Print Name of Participant________________________________________________ 
 
Signature of Participant _________________________________________________ 
 
Date _________________________________ 







Print Name of Researcher/person taking the consent_____________________________________ 
     
Signature of Researcher /person taking the consent______________________________________ 
 
Date _________________________________    
Day/month/year 
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